A physiologically-based drug absorption modeling for orally disintegrating tablets

被引:7
作者
Kambayashi, Atsushi [1 ]
Kiyota, Tsuyoshi [1 ]
机构
[1] Astellas Pharma Inc, Pharmaceut Res & Technol Labs, 180 Ozumi, Yaizu, Shizuoka 4250072, Japan
关键词
Orally disintegrating tablets; Orodispersible tablets; In vitro biorelevant dissolution; In silico modeling and simulation; Pharmacokinetics; Oral drug absorption; Atorvastatin; IN-VIVO APPROACH; PHARMACOKINETIC PROFILES; ORODISPERSIBLE TABLETS; DOSAGE FORMS; DISSOLUTION; SIMULATION; FORMULATION; BIOAVAILABILITY; BIOEQUIVALENCE; TRANSIT;
D O I
10.1016/j.ejpb.2020.04.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this research was to simulate oral pharmacokinetic (PK) profiles of atorvastatin from orally disintegrating tablets (ODTs) dosed without water ingestion in fasted humans. The in vitro dissolution profiles of three different formulations of ODTs were evaluated with fasted state biorelevant media using a paddle dissolution apparatus, and the results were coupled with an in silico model to simulate the in vivo oral PK profiles of ODTs following administration to humans. Since the dissolution rates of the ODTs in the intestinal medium (FaSSIF-V2) were highly affected by pre-exposure of the tablets to the stomach medium (FaSSGF), the simulation model took account of the relationship between the gastric emptying time and the dissolution performance of the tablets in the small intestine. The ODTs were formulated with drug-containing pellets. After oral dosing of the ODTs without water ingestion, gastric emptying of the pellets was assumed to follow first order kinetics. Thus, rate constants ranging between 0.69 and 8.3 h(-1) were applied in the PK simulations. The simulation model was built using Stella Professional (R) software. The results of the PK simulations suggest that the plasma concentration profiles of the ODTs can be described using the prediction model, but that different gastric emptying parameters for each ODT formulation are needed in humans.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 39 条
  • [1] Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine
    Ali, Joseph
    Zgair, Atheer
    Hameed, Ghaidaa S.
    Garnett, Martin C.
    Roberts, Clive J.
    Burley, Jonathan C.
    Gershkovich, Pavel
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 555 : 228 - 236
  • [2] [Anonymous], 2011, Patent Appliation, Patent No. [WO2011/121824, 2011121824]
  • [3] [Anonymous], 2011, Patent Application, Patent No. [WO2011/121823, 2011121823]
  • [4] The effect of polyethylene glycol 400 on gastrointestinal transit: Implications for the formulation of poorly-water soluble drugs
    Basit, AW
    Newton, JM
    Short, MD
    Waddington, WA
    Ell, PJ
    Lacey, LF
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (08) : 1146 - 1150
  • [5] Bioequivalence of Ondansetron Oral Soluble Film 8 mg (ZUPLENZ) and Ondansetron Orally Disintegrating Tablets 8 mg (ZOFRAN) in Healthy Adults
    Dadey, Eric
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (02) : 90 - 97
  • [6] Pharmacokinetics of a Novel Orodispersible Tablet of Sildenafil in Healthy Subjects
    Damle, Bharat
    Duczynski, Gregory
    Jeffers, Barrett W.
    Crownover, Penelope
    Coupe, Alastair
    LaBadie, Robert R.
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (02) : 236 - 244
  • [7] Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability
    Dennison, Thomas J.
    Smith, Julian C.
    Badhan, Raj K.
    Mohammed, Afzal R.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 811 - 826
  • [8] Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine
    Drozdzik, Marek
    Groeer, Christian
    Penski, Jette
    Lapczuk, Joanna
    Ostrowski, Marek
    Lai, Yurong
    Prasad, Bhagwat
    Unadkat, Jashvant D.
    Siegmund, Werner
    Oswald, Stefan
    [J]. MOLECULAR PHARMACEUTICS, 2014, 11 (10) : 3547 - 3555
  • [9] New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook
    Elwerfalli, Arwa Matoug
    Ghanchi, Zabir
    Rashid, Fatema
    Alany, Raid G.
    ElShaer, Amr
    [J]. CURRENT DRUG DELIVERY, 2016, 12 (06) : 652 - 667
  • [10] Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese
    Fukazawa, I
    Uchida, N
    Uchida, E
    Yasuhara, H
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (04) : 448 - 455